MedPath

Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

Phase 3
Completed
Conditions
Myocardial Infarction
Sudden Death
Registration Number
NCT00673842
Lead Sponsor
University of Calgary
Brief Summary

This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.

Detailed Description

The REFINE ICD trial will assess whether prophylactic ICD therapy, guided by non-invasive risk assessment tools, reduces mortality in MI survivors with better-preserved LV function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
700
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
MortalityMinimum of 18 months of follow-up (average follow-up of 5 years).
Secondary Outcome Measures
NameTimeMethod
Appropriate ICD therapiesAverage follow-up 5 years.
Arrhythmic syncopeAverage follow-up 5 years.
Arrhythmic deathAverage follow-up 5 years.
Inappropriate ICD therapiesFive years (average)
Quality of lifeAverage follow-up 5 years.
Cardiac deathAverage follow-up 5 years.

Trial Locations

Locations (78)

Heart Center Research LLC

🇺🇸

Huntsville, Alabama, United States

Colorado Heart and Vascular

🇺🇸

Lakewood, Colorado, United States

James A Haley Veterans' Center

🇺🇸

Tampa, Florida, United States

The Heart Group/Deaconess

🇺🇸

Evansville, Indiana, United States

Iowa Heart Center

🇺🇸

West Des Moines, Iowa, United States

Delmarva Heart Foundation

🇺🇸

Salisbury, Maryland, United States

Beth Israel Deaconess

🇺🇸

Boston, Massachusetts, United States

Washington University Medical School

🇺🇸

Saint Louis, Michigan, United States

St. John Providence Hospital

🇺🇸

Southfield, Michigan, United States

Lester E Cox Medical Center

🇺🇸

Springfield, Missouri, United States

Scroll for more (68 remaining)
Heart Center Research LLC
🇺🇸Huntsville, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.